Oxygen Therapy Market Analysis By Product (Oxygen Source Equipment, Cylinders, Concentrators, Liquid Oxygen Devices, PAP, Oxygen Delivery Device, Masks, Nasal Cannula, Venturi Mask, Non Rebreather Mask, Bag Valve, CPAP), By Application (Chronic Obstructive Pulmonary Disease, Asthma, Obstructive Sleep Apnea, Respiratory Distress Syndrome, Cystic Fibrosis, Pneumonia), By End-use (Home Healthcare, Hospitals), And Segment Forecasts To 2024
The global oxygen therapy market is expected to reach USD 18.2 billion by 2024, according to a new study by Grand View Research, Inc. The increasing prevalence of major respiratory diseases, such as Chronic Obstructive Pulmonary Disease (COPD), asthma, and obstructive sleep apnea, is a high impact rendering driver of oxygen therapy market.
As per the estimates of the WHO, a consequential global rise in the prevalence of asthma and other respiratory disorders, is expected to heightened clinical urgency to treat the aforementioned disorders and is expected to boost the demand for oxygen therapy as the first line treatment and as a supplement in various applications.
Moreover, technological advancements are anticipated to provide growth platforms in a wide range of new applications such as cancer and diabetes; for instance, incorporation of flow sensors in delivery devices to conserve and regulate the flow enabling greater patient comfort and outcomes.
Furthermore, the increasing focus on home healthcare solutions coupled with the development of portable delivery devices has a major impact on the oxygen therapy market. These aforementioned factors are expected to serve as key contributing factors towards the growth of the oxygen therapy market over the forecast period.
Further key findings from the study suggest:
The oxygen source equipment segment dominated the product segment in terms of revenue share in 2015owing toits high usage rate and wide scale availability in various forms such as liquid compressed gas, and concentrators. On the other hand, oxygen delivery devices are expected to grow at a lucrative rate being an indispensable part of the oxygen therapy set-ups, thereby contributing towards the overall oxygen therapy market growth during the forecast period.
Oxygen concentrator spear headed the source equipment market segment owing to rising popularity and adoption of Portable Concentrators in emergency medicine, ambulatory, and home settings.
Oxygen masks dominated delivery device market segment at over USD 800.0 million in 2015, as a consequence of being the indispensable unit of the delivery system and greater availability of specialty masks as per the patient’s physiological needs
Chronic Obstructive Pulmonary Disease (COPD) held a substantial market share of application segment and constituted for over 37.0%of the overall revenue share, owing to presence of unmet needs pertinent to COPD treatment, thereby propelling the demand for oxygen therapy market
Home Healthcare is anticipated to grow lucratively at CAGR of 11.8% owing to associated benefits such as long-term cost efficiency and increased mobility, propelling the demand over the forecast period. Moreover, presence of organizations such American Association for Homecare to promote awareness and strengthen home healthcare are expected to provide growth platform in future to oxygen therapy market
The key players in this industry include CareFusion, Corp., Tecno-Gaz Industries, GE Healthcare, Hersill, DeVilbiss Healthcare, Philips Respironics, Inc., MAQUET Medical Systems, Allied Healthcare Products, Smiths Medical, Fisher & Paykel Healthcare Limited, Invacare Corporation and Teleflex Incorporated
These industry players are adopting strategies such as new product development, technological innovation, and strategic collaborations, such as mergers &acquisitions, to capitalize their industry share. For instance, in May 2015, Fisher & Paykel Healthcare launched AIRVO nasal high-flow system to expand its product portfolio and capture greater share of oxygen therapy market.
As per the estimates of the WHO, a consequential global rise in the prevalence of asthma and other respiratory disorders, is expected to heightened clinical urgency to treat the aforementioned disorders and is expected to boost the demand for oxygen therapy as the first line treatment and as a supplement in various applications.
Moreover, technological advancements are anticipated to provide growth platforms in a wide range of new applications such as cancer and diabetes; for instance, incorporation of flow sensors in delivery devices to conserve and regulate the flow enabling greater patient comfort and outcomes.
Furthermore, the increasing focus on home healthcare solutions coupled with the development of portable delivery devices has a major impact on the oxygen therapy market. These aforementioned factors are expected to serve as key contributing factors towards the growth of the oxygen therapy market over the forecast period.
Further key findings from the study suggest:
The oxygen source equipment segment dominated the product segment in terms of revenue share in 2015owing toits high usage rate and wide scale availability in various forms such as liquid compressed gas, and concentrators. On the other hand, oxygen delivery devices are expected to grow at a lucrative rate being an indispensable part of the oxygen therapy set-ups, thereby contributing towards the overall oxygen therapy market growth during the forecast period.
Oxygen concentrator spear headed the source equipment market segment owing to rising popularity and adoption of Portable Concentrators in emergency medicine, ambulatory, and home settings.
Oxygen masks dominated delivery device market segment at over USD 800.0 million in 2015, as a consequence of being the indispensable unit of the delivery system and greater availability of specialty masks as per the patient’s physiological needs
Chronic Obstructive Pulmonary Disease (COPD) held a substantial market share of application segment and constituted for over 37.0%of the overall revenue share, owing to presence of unmet needs pertinent to COPD treatment, thereby propelling the demand for oxygen therapy market
Home Healthcare is anticipated to grow lucratively at CAGR of 11.8% owing to associated benefits such as long-term cost efficiency and increased mobility, propelling the demand over the forecast period. Moreover, presence of organizations such American Association for Homecare to promote awareness and strengthen home healthcare are expected to provide growth platform in future to oxygen therapy market
The key players in this industry include CareFusion, Corp., Tecno-Gaz Industries, GE Healthcare, Hersill, DeVilbiss Healthcare, Philips Respironics, Inc., MAQUET Medical Systems, Allied Healthcare Products, Smiths Medical, Fisher & Paykel Healthcare Limited, Invacare Corporation and Teleflex Incorporated
These industry players are adopting strategies such as new product development, technological innovation, and strategic collaborations, such as mergers &acquisitions, to capitalize their industry share. For instance, in May 2015, Fisher & Paykel Healthcare launched AIRVO nasal high-flow system to expand its product portfolio and capture greater share of oxygen therapy market.
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Research Methodology
1.2. Research Scope & Assumptions
1.3. List of Data Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Oxygen Therapy Market- Industry Snapshot and Key Buying Criteria, 2015
CHAPTER 3. OXYGEN THERAPY INDUSTRY OUTLOOK
3.1. Oxygen Therapy Market Segmentation
3.2. Oxygen Therapy Market Size and Growth Prospects
3.3. Oxygen Therapy Market Dynamics
3.3.1. Market Driver Analysis
3.3.1.1. Rising incidences of respiratory diseases
3.3.1.2. Technological advancements
3.3.2. Market Restraint Analysis
3.3.2.1. Complex regulatory framework
3.4. Key Opportunities Prioritized
3.5. Oxygen Therapy Competitive Landscape, 2015
3.5.1. Company Market Share Analysis, 2015
3.5.2. Competitive Landscape: Market Position Analysis (based on products, regional presence and strategic initiatives)
3.6. Industry Analysis - Porter's
3.7. Oxygen Therapy Market PESTEL Analysis, 2015
CHAPTER 4. OXYGEN THERAPY PRODUCT OUTLOOK
4.1. Oxygen Therapy Market Share By Product, 2015 & 2024
4.2. Oxygen Source Equipment
4.2.1. Oxygen Source Equipment Market Estimates and Forecasts, 2014 - 2024
4.2.2. Oxygen Cylinders
4.2.2.1. Oxygen Cylinders Market Estimates and Forecasts, 2014 - 2024
4.2.3. Oxygen Concentrators
4.2.3.1. Oxygen Concentrators Market Estimates and Forecasts, 2014 - 2024
4.2.4. Liquid Oxygen Devices
4.2.4.1. Liquid Oxygen Devices Market Estimates and Forecasts, 2014 - 2024
4.2.5. PAP Devices
4.2.5.1. PAP Devices Market Estimates and Forecasts, 2014 - 2024
4.3. Oxygen Delivery Devices
4.3.1. Oxygen Delivery Devices Market Estimates and Forecasts, 2014 - 2024
4.3.2. Oxygen Masks
4.3.2.1. Oxygen Masks Market Estimates and Forecasts, 2014 - 2024
4.3.3. Nasal Cannula
4.3.3.1. Nasal Cannula Market Estimates and Forecasts, 2014 - 2024
4.3.4. Venturi Masks
4.3.4.1. Venturi Masks Market Estimates and Forecasts, 2014 - 2024
4.3.5. Non-rebreather Masks
4.3.5.1. Non-rebreather Masks Market Estimates and Forecasts, 2014 - 2024
4.3.6. Bag Valve Masks
4.3.6.1. Bag Valve Masks Market Estimates and Forecasts, 2014 - 2024
4.3.7. CPAP Masks
4.3.7.1. CPAP Masks Market Estimates and Forecasts, 2014 - 2024
4.3.8. Others
4.3.8.1. Others Market Estimates and Forecasts, 2014 - 2024
CHAPTER 5. OXYGEN THERAPY APPLICATION OUTLOOK
5.1. Oxygen Therapy Market Share By Application, 2015 & 2024
5.2. Chronic Obstructive Pulmonary Disease
5.2.1. Chronic Obstructive Pulmonary Disease Market Estimates and Forecasts, 2014 - 2024
5.3. Asthma
5.3.1. Asthma Market Estimates and Forecasts, 2014 - 2024
5.4. Obstructive Sleep Apnea
5.4.1. Obstructive Sleep Apnea Market Estimates and Forecasts, 2014 - 2024
5.5. Respiratory Distress Syndrome
5.5.1. Respiratory Distress Syndrome Market Estimates and Forecasts, 2014 - 2024
5.6. Cystic Fibrosis
5.6.1. Cystic Fibrosis Market Estimates and Forecasts, 2014 - 2024
5.7. Pneumonia
5.7.1. Pneumonia Market Estimates and Forecasts, 2014 - 2024
5.8. Others
5.8.1. Others Market Estimates and Forecasts, 2014 - 2024
CHAPTER 6. OXYGEN THERAPY END-USE OUTLOOK
6.1. Oxygen Therapy Market Share By End-use, 2015 & 2024
6.2. Home Healthcare
6.2.1. Home Healthcare Market Estimates and Forecasts, 2014 - 2024
6.3. Hospital
6.3.1. Hospital Market Estimates and Forecasts, 2014 - 2024
CHAPTER 7. OXYGEN THERAPY REGIONAL OUTLOOK
7.1. Oxygen Therapy Market Share By Region, 2015 & 2024
7.2. North America
7.2.1. North America Market Estimates and Forecasts, By Product, 2014 - 2024 (USD Million)
7.2.1.1. U.S. Market Estimates and Forecasts
7.2.1.2. Canada Market Estimates and Forecasts
7.2.2. North America Market Estimates and Forecasts, By Application, 2014 - 2024 (USD Million)
7.2.2.1. U.S. Market Estimates and Forecasts
7.2.2.2. Canada Market Estimates and Forecasts
7.2.3. North America Market Estimates and Forecasts, By End-use, 2014 - 2024 (USD Million)
7.2.3.1. U.S. Market Estimates and Forecasts
7.2.3.2. Canada Market Estimates and Forecasts
7.3. Europe
7.3.1. Europe Market Estimates and Forecasts, By Product, 2014 - 2024 (USD Million)
7.3.1.1. UK Market Estimates and Forecasts
7.3.1.2. Germany Market Estimates and Forecasts
7.3.2. Europe Market Estimates and Forecasts, By Application, 2014 - 2024 (USD Million)
7.3.2.1. UK Market Estimates and Forecasts
7.3.2.2. Germany Market Estimates and Forecasts
7.3.3. Europe Market Estimates and Forecasts, By End-use, 2014 - 2024 (USD Million)
7.3.3.1. UK Market Estimates and Forecasts
7.3.3.2. Germany Market Estimates and Forecasts
7.4. Asia Pacific
7.4.1. Asia Pacific Market Estimates and Forecasts, By Product, 2014 - 2024 (USD Million)
7.4.1.1. Japan Market Estimates and Forecasts
7.4.1.2. China Market Estimates and Forecasts
7.4.1.3. India Market Estimates and Forecasts
7.4.2. Asia Pacific Market Estimates and Forecasts, By Application, 2014 - 2024 (USD Million)
7.4.2.1. Japan Market Estimates and Forecasts
7.4.2.2. China Market Estimates and Forecasts
7.4.2.3. India Market Estimates and Forecasts
7.4.3. Asia Pacific Market Estimates and Forecasts, By End-use, 2014 - 2024 (USD Million)
7.4.3.1. Japan Market Estimates and Forecasts
7.4.3.2. China Market Estimates and Forecasts
7.4.3.3. India Market Estimates and Forecasts
7.5. Latin America
7.5.1. Latin America Market Estimates and Forecasts, By Product, 2014 - 2024 (USD Million)
7.5.1.1. Brazil Market Estimates and Forecasts
7.5.1.2. Mexico Market Estimates and Forecasts
7.5.2. Latin America Market Estimates and Forecasts, By Application, 2014 - 2024 (USD Million)
7.5.2.1. Brazil Market Estimates and Forecasts
7.5.2.2. Mexico Market Estimates and Forecasts
7.5.3. Latin America Market Estimates and Forecasts, By End-use, 2014 - 2024 (USD Million)
7.5.3.1. Brazil Market Estimates and Forecasts
7.5.3.2. Mexico Market Estimates and Forecasts
7.6. MEA
7.6.1. MEA Market Estimates and Forecasts, By Product, 2014 - 2024 (USD Million)
7.6.1.1. South Africa Market Estimates and Forecasts
7.6.2. MEA Market Estimates and Forecasts, By Application, 2014 - 2024 (USD Million)
7.6.2.1. South Africa Market Estimates and Forecasts
7.6.3. MEA Market Estimates and Forecasts, By End-use, 2014 - 2024 (USD Million)
7.6.3.1. South Africa Market Estimates and Forecasts
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. CareFusion Inc.
8.1.1. Company Overview
8.1.2. Financial Performance
8.1.3. Product Benchmarking
8.1.4. Strategic Initiatives
8.2. GE Healthcare
8.2.1. Company Overview
8.2.2. Financial Performance
8.2.3. Product Benchmarking
8.2.4. Strategic Initiatives
8.3. Tecno-Gaz Indsutries
8.3.1. Company Overview
8.3.2. Financial Performance
8.3.3. Product Benchmarking
8.3.4. Strategic Initiatives
8.4. Hersill
8.4.1. Company Overview
8.4.2. Financial Performance
8.4.3. Product Benchmarking
8.4.4. Strategic Initiatives
8.5. Philips Respironics, Inc
8.5.1. Company Overview
8.5.2. Financial Performance
8.5.3. Product Benchmarking
8.5.4. Strategic Initiatives
8.6. DeVilbiss Healthcare
8.6.1. Company Overview
8.6.2. Financial Performance
8.6.3. Product Benchmarking
8.6.4. Strategic Initiatives’
8.7. MAQUET Medical Systems
8.7.1. Company Overview
8.7.2. Financial Performance
8.7.3. Product Benchmarking
8.7.4. Strategic Initiatives
8.8. Smith’s Medical
8.8.1. Company Overview
8.8.2. Financial Performance
8.8.3. Product Benchmarking
8.8.4. Strategic Initiatives
8.9. Allied Healthcare Products
8.9.1. Company Overview
8.9.2. Financial Performance
8.9.3. Product Benchmarking
8.9.4. Strategic Initiatives
8.10. Fisher & Paykel Healthcare Limited
8.10.1. Company Overview
8.10.2. Financial Performance
8.10.3. Product Benchmarking
8.10.4. Strategic Initiatives
8.11. Teleflex Incorporated
8.11.1. Company Overview
8.11.2. Financial Performance
8.11.3. Product Benchmarking
8.11.4. Strategic Initiatives
8.12. Invacare Corporation
8.12.1. Company Overview
8.12.2. Financial Performance
8.12.3. Product Benchmarking
8.12.4. Strategic Initiatives
8.13. Chart Industries
8.13.1. Company Overview
8.13.2. Financial Performance
8.13.3. Product Benchmarking
8.13.4. Strategic Initiatives
1.1. Research Methodology
1.2. Research Scope & Assumptions
1.3. List of Data Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Oxygen Therapy Market- Industry Snapshot and Key Buying Criteria, 2015
CHAPTER 3. OXYGEN THERAPY INDUSTRY OUTLOOK
3.1. Oxygen Therapy Market Segmentation
3.2. Oxygen Therapy Market Size and Growth Prospects
3.3. Oxygen Therapy Market Dynamics
3.3.1. Market Driver Analysis
3.3.1.1. Rising incidences of respiratory diseases
3.3.1.2. Technological advancements
3.3.2. Market Restraint Analysis
3.3.2.1. Complex regulatory framework
3.4. Key Opportunities Prioritized
3.5. Oxygen Therapy Competitive Landscape, 2015
3.5.1. Company Market Share Analysis, 2015
3.5.2. Competitive Landscape: Market Position Analysis (based on products, regional presence and strategic initiatives)
3.6. Industry Analysis - Porter's
3.7. Oxygen Therapy Market PESTEL Analysis, 2015
CHAPTER 4. OXYGEN THERAPY PRODUCT OUTLOOK
4.1. Oxygen Therapy Market Share By Product, 2015 & 2024
4.2. Oxygen Source Equipment
4.2.1. Oxygen Source Equipment Market Estimates and Forecasts, 2014 - 2024
4.2.2. Oxygen Cylinders
4.2.2.1. Oxygen Cylinders Market Estimates and Forecasts, 2014 - 2024
4.2.3. Oxygen Concentrators
4.2.3.1. Oxygen Concentrators Market Estimates and Forecasts, 2014 - 2024
4.2.4. Liquid Oxygen Devices
4.2.4.1. Liquid Oxygen Devices Market Estimates and Forecasts, 2014 - 2024
4.2.5. PAP Devices
4.2.5.1. PAP Devices Market Estimates and Forecasts, 2014 - 2024
4.3. Oxygen Delivery Devices
4.3.1. Oxygen Delivery Devices Market Estimates and Forecasts, 2014 - 2024
4.3.2. Oxygen Masks
4.3.2.1. Oxygen Masks Market Estimates and Forecasts, 2014 - 2024
4.3.3. Nasal Cannula
4.3.3.1. Nasal Cannula Market Estimates and Forecasts, 2014 - 2024
4.3.4. Venturi Masks
4.3.4.1. Venturi Masks Market Estimates and Forecasts, 2014 - 2024
4.3.5. Non-rebreather Masks
4.3.5.1. Non-rebreather Masks Market Estimates and Forecasts, 2014 - 2024
4.3.6. Bag Valve Masks
4.3.6.1. Bag Valve Masks Market Estimates and Forecasts, 2014 - 2024
4.3.7. CPAP Masks
4.3.7.1. CPAP Masks Market Estimates and Forecasts, 2014 - 2024
4.3.8. Others
4.3.8.1. Others Market Estimates and Forecasts, 2014 - 2024
CHAPTER 5. OXYGEN THERAPY APPLICATION OUTLOOK
5.1. Oxygen Therapy Market Share By Application, 2015 & 2024
5.2. Chronic Obstructive Pulmonary Disease
5.2.1. Chronic Obstructive Pulmonary Disease Market Estimates and Forecasts, 2014 - 2024
5.3. Asthma
5.3.1. Asthma Market Estimates and Forecasts, 2014 - 2024
5.4. Obstructive Sleep Apnea
5.4.1. Obstructive Sleep Apnea Market Estimates and Forecasts, 2014 - 2024
5.5. Respiratory Distress Syndrome
5.5.1. Respiratory Distress Syndrome Market Estimates and Forecasts, 2014 - 2024
5.6. Cystic Fibrosis
5.6.1. Cystic Fibrosis Market Estimates and Forecasts, 2014 - 2024
5.7. Pneumonia
5.7.1. Pneumonia Market Estimates and Forecasts, 2014 - 2024
5.8. Others
5.8.1. Others Market Estimates and Forecasts, 2014 - 2024
CHAPTER 6. OXYGEN THERAPY END-USE OUTLOOK
6.1. Oxygen Therapy Market Share By End-use, 2015 & 2024
6.2. Home Healthcare
6.2.1. Home Healthcare Market Estimates and Forecasts, 2014 - 2024
6.3. Hospital
6.3.1. Hospital Market Estimates and Forecasts, 2014 - 2024
CHAPTER 7. OXYGEN THERAPY REGIONAL OUTLOOK
7.1. Oxygen Therapy Market Share By Region, 2015 & 2024
7.2. North America
7.2.1. North America Market Estimates and Forecasts, By Product, 2014 - 2024 (USD Million)
7.2.1.1. U.S. Market Estimates and Forecasts
7.2.1.2. Canada Market Estimates and Forecasts
7.2.2. North America Market Estimates and Forecasts, By Application, 2014 - 2024 (USD Million)
7.2.2.1. U.S. Market Estimates and Forecasts
7.2.2.2. Canada Market Estimates and Forecasts
7.2.3. North America Market Estimates and Forecasts, By End-use, 2014 - 2024 (USD Million)
7.2.3.1. U.S. Market Estimates and Forecasts
7.2.3.2. Canada Market Estimates and Forecasts
7.3. Europe
7.3.1. Europe Market Estimates and Forecasts, By Product, 2014 - 2024 (USD Million)
7.3.1.1. UK Market Estimates and Forecasts
7.3.1.2. Germany Market Estimates and Forecasts
7.3.2. Europe Market Estimates and Forecasts, By Application, 2014 - 2024 (USD Million)
7.3.2.1. UK Market Estimates and Forecasts
7.3.2.2. Germany Market Estimates and Forecasts
7.3.3. Europe Market Estimates and Forecasts, By End-use, 2014 - 2024 (USD Million)
7.3.3.1. UK Market Estimates and Forecasts
7.3.3.2. Germany Market Estimates and Forecasts
7.4. Asia Pacific
7.4.1. Asia Pacific Market Estimates and Forecasts, By Product, 2014 - 2024 (USD Million)
7.4.1.1. Japan Market Estimates and Forecasts
7.4.1.2. China Market Estimates and Forecasts
7.4.1.3. India Market Estimates and Forecasts
7.4.2. Asia Pacific Market Estimates and Forecasts, By Application, 2014 - 2024 (USD Million)
7.4.2.1. Japan Market Estimates and Forecasts
7.4.2.2. China Market Estimates and Forecasts
7.4.2.3. India Market Estimates and Forecasts
7.4.3. Asia Pacific Market Estimates and Forecasts, By End-use, 2014 - 2024 (USD Million)
7.4.3.1. Japan Market Estimates and Forecasts
7.4.3.2. China Market Estimates and Forecasts
7.4.3.3. India Market Estimates and Forecasts
7.5. Latin America
7.5.1. Latin America Market Estimates and Forecasts, By Product, 2014 - 2024 (USD Million)
7.5.1.1. Brazil Market Estimates and Forecasts
7.5.1.2. Mexico Market Estimates and Forecasts
7.5.2. Latin America Market Estimates and Forecasts, By Application, 2014 - 2024 (USD Million)
7.5.2.1. Brazil Market Estimates and Forecasts
7.5.2.2. Mexico Market Estimates and Forecasts
7.5.3. Latin America Market Estimates and Forecasts, By End-use, 2014 - 2024 (USD Million)
7.5.3.1. Brazil Market Estimates and Forecasts
7.5.3.2. Mexico Market Estimates and Forecasts
7.6. MEA
7.6.1. MEA Market Estimates and Forecasts, By Product, 2014 - 2024 (USD Million)
7.6.1.1. South Africa Market Estimates and Forecasts
7.6.2. MEA Market Estimates and Forecasts, By Application, 2014 - 2024 (USD Million)
7.6.2.1. South Africa Market Estimates and Forecasts
7.6.3. MEA Market Estimates and Forecasts, By End-use, 2014 - 2024 (USD Million)
7.6.3.1. South Africa Market Estimates and Forecasts
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. CareFusion Inc.
8.1.1. Company Overview
8.1.2. Financial Performance
8.1.3. Product Benchmarking
8.1.4. Strategic Initiatives
8.2. GE Healthcare
8.2.1. Company Overview
8.2.2. Financial Performance
8.2.3. Product Benchmarking
8.2.4. Strategic Initiatives
8.3. Tecno-Gaz Indsutries
8.3.1. Company Overview
8.3.2. Financial Performance
8.3.3. Product Benchmarking
8.3.4. Strategic Initiatives
8.4. Hersill
8.4.1. Company Overview
8.4.2. Financial Performance
8.4.3. Product Benchmarking
8.4.4. Strategic Initiatives
8.5. Philips Respironics, Inc
8.5.1. Company Overview
8.5.2. Financial Performance
8.5.3. Product Benchmarking
8.5.4. Strategic Initiatives
8.6. DeVilbiss Healthcare
8.6.1. Company Overview
8.6.2. Financial Performance
8.6.3. Product Benchmarking
8.6.4. Strategic Initiatives’
8.7. MAQUET Medical Systems
8.7.1. Company Overview
8.7.2. Financial Performance
8.7.3. Product Benchmarking
8.7.4. Strategic Initiatives
8.8. Smith’s Medical
8.8.1. Company Overview
8.8.2. Financial Performance
8.8.3. Product Benchmarking
8.8.4. Strategic Initiatives
8.9. Allied Healthcare Products
8.9.1. Company Overview
8.9.2. Financial Performance
8.9.3. Product Benchmarking
8.9.4. Strategic Initiatives
8.10. Fisher & Paykel Healthcare Limited
8.10.1. Company Overview
8.10.2. Financial Performance
8.10.3. Product Benchmarking
8.10.4. Strategic Initiatives
8.11. Teleflex Incorporated
8.11.1. Company Overview
8.11.2. Financial Performance
8.11.3. Product Benchmarking
8.11.4. Strategic Initiatives
8.12. Invacare Corporation
8.12.1. Company Overview
8.12.2. Financial Performance
8.12.3. Product Benchmarking
8.12.4. Strategic Initiatives
8.13. Chart Industries
8.13.1. Company Overview
8.13.2. Financial Performance
8.13.3. Product Benchmarking
8.13.4. Strategic Initiatives
